3 (1, 2a, 2b), 11532
While oral glutathione is generally considered to be safe, there is not enough data to recommend long-term use, especially for women who are pregnant or breastfeeding, people who take prescription or over-the-counter drugs, and those who have chronic conditions, says Malhotra
Even so, Novo Nordisk is requesting a label change in the European Union to encourage people to take Rybelsus for cardiovascular issues, too
No randomized controlled trial has compared alternating GLP-1 medications against staying on a single medication through a plateau
If possible, reduce the dilution factor of the pretreatment or increase the sample volume to increase the concentration of the sample above the measuring range
Swap that GLP-1 component for a more potent triple agonist like Retatrutide and the mechanistic ceiling, at least on paper, sits higher still